Helix Announces $50M Series C to Accelerate into Population Genomics
Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C funding round led by existing investors Warburg Pincus, DFJ Growth, Kleiner...
Tag : genomics
GATC Health’s AI-aided Genomics Recognized as High Value Booster
The value of GATC Health’s AI-powered approach to genomics continues to gain attention as a solution for rapid drug discovery and highly accurate diagnostic tools. The...
Personal Genome DiagnosticsDiagnostics Launches elio™ plasma complete
Provides analysis of over 500 genes and select amplifications and rearrangements – Developed to enable researchers to harness next-generation sequencing (NGS) tools to empower new...
Personalis Announces Delivery of the 125,000th Genome
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, announced today that it has delivered the 125,000th whole human genome...
WhiteLab Genomics and the ART-TG Announce Their Collaboration
WhiteLab Genomics, specialist in artificial intelligence (AI) dedicated to gene and cell therapies, is entering into a collaboration with ART-TG, Inserm laboratory expert in the...
Gene Therapy Co. GenSight Biologics to Host a Webinar
GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and...
Genomics-enabled Illumina To Webcast Upcoming Investor Conference
Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Goldman Sachs 42nd Annual Global Healthcare Conference on June...
Genomic Diagnostics Company, Veracyte to Present at Conferences
Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, announced today that Bonnie H. Anderson, chairman, chief executive officer and incoming executive chairman, and Marc...
Moderna and Aldevron Expand Partnership for mRNA Vaccine
Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and...
Genomic Medicine Company Sangamo Therapeutics Appoints New CFO
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Prathyusha Duraibabu, CPA, MBA as Senior Vice President and Chief Financial...